Phase II Study of Redefining The Use Of A FOLFIRINOX-Like Regimen In the Front Line In Older Patients With Metastatic Pancreatic Cancer
Summary
The purpose of this phase II trial is to evaluate the safety and tolerability of FOLFIRINOX in patients aged 65 and older with pancreatic cancer.
General Information
NCT#: NCT05360732
Study ID: GI-170
Trial Phase: Phase II
Trial Sponsor: Fox Chase Cancer Center
Therapies Used in This Trial: FOLFIRINOX